{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:48:16Z","timestamp":1790732896307,"version":"4.1.0"},"reference-count":43,"publisher":"Japanese Society of Toxicology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2131\/jts.42.773","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T22:20:53Z","timestamp":1510784453000},"page":"773-788","source":"Crossref","is-referenced-by-count":30,"title":["Evaluation of the human relevance of the constitutive androstane receptor-mediated mode of action for rat hepatocellular tumor formation by the synthetic pyrethroid momfluorothrin"],"prefix":"10.2131","volume":"42","author":[{"given":"Yu","family":"Okuda","sequence":"first","affiliation":[{"name":"Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd."},{"name":"Graduate School of Environmental and Life Science, Okayama University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kushida","sequence":"additional","affiliation":[{"name":"Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Kikumoto","sequence":"additional","affiliation":[{"name":"Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Graduate School of Environmental and Life Science, Okayama University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashihiro","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel M.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Canter, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Lake","sequence":"additional","affiliation":[{"name":"Centre for Toxicology, Faculty of Health and Medical Sciences, University of Surrey, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Yamada","sequence":"additional","affiliation":[{"name":"Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aiges, H.W., Daum, F., Olson, M., Kahn, E. and Teichberg, S. (1980): The effects of phenobarbital and diphenylhydantoin on liver function and morphology. J. Pediatr., <b>97<\/b>, 22-26.","DOI":"10.1016\/S0022-3476(80)80123-5"},{"key":"2","unstructured":"ATSDR (2003): Toxicological profile for Pyrethrins and Pyrethroids. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry (ATSDR).), Atlanta, GA."},{"key":"3","doi-asserted-by":"crossref","unstructured":"Boobis, A.R., Cohen, S.M., Dellarco, V., McGregor, D., Meek, M.E., Vickers, C., Willcocks, D. and Farland, W. (2006): IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol., <b>36<\/b>, 781-792.","DOI":"10.1080\/10408440600977677"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Boobis, A.R., Doe, J.E., Heinrich-Hirsch, B., Meek, M.E., Munn, S., Ruchirawat, M., Schlatter, J., Seed, J. and Vickers, C. (2008): IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit. Rev. Toxicol., <b>38<\/b>, 87-96.","DOI":"10.1080\/10408440701749421"},{"key":"5","unstructured":"Braeuning, A. (2014): Liver cell proliferation and tumor promotion by phenobarbital: relevance for humans? Arch. Toxicol., <b>88<\/b>, 1771-1772."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Braeuning, A., Gavrilov, A., Brown, S., Wolf, C.R., Henderson, C.J. and Schwarz, M. (2014): Phenobarbital-mediated tumor promotion in transgenic mice with humanized CAR and PXR. Toxicol. Sci., <b>140<\/b>, 259-270.","DOI":"10.1093\/toxsci\/kfu099"},{"key":"7","unstructured":"Braeuning, A., Henderson, C.J., Wolf, C.R. and Schwarz, M. (2015): Model systems for understanding mechanisms of nongenotoxic carcinogenesis: response. Toxicol. Sci., <b>147<\/b>, 299-300."},{"key":"8","unstructured":"Braeuning, A. and Schwarz, M. (2016): Is the question of phenobarbital as potential liver cancer risk factor for humans really resolved? Arch. Toxicol., <b>90<\/b>, 1525-1526."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Cohen, S.M. (2010): Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary. Toxicol. Pathol., <b>38<\/b>, 487-501.","DOI":"10.1177\/0192623310363813"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Cohen, S.M., Klaunig, J., Meek, M.E., Hill, R.N., Pastoor, T., Lehman-McKeeman, L., Bucher, J., Longfellow, D.G., Seed, J., Dellarco, V., Fenner-Crisp, P. and Patton, D. (2004): Evaluating the human relevance of chemically induced animal tumors. Toxicol. Sci., <b>78<\/b>, 181-186.","DOI":"10.1093\/toxsci\/kfh073"},{"key":"11","unstructured":"ECHA (2014): CLH report, Proposal for Harmonised Classification and Labelling Based on Regulation (EC) No 1272\/2008 (CLP Regulation), Annex VI, Part 2. Substance Name: 1R-trans-Z-momfluorothrin. https:\/\/echa.europa.eu\/documents\/10162\/13626\/clh_proposal_1r_trans_z_momfluorothrin_en.pdf\/34bf8211-758e-4cf5-a4d9-bfe616464965. Accessed date: August 17, 2017."},{"key":"12","doi-asserted-by":"crossref","unstructured":"Elcombe, C.R., Odum, J., Foster, J.R., Stone, S., Hasmall, S., Soames, A.R., Kimber, I. and Ashby, J. (2002): Prediction of rodent nongenotoxic carcinogenesis: evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens. Environ. Health Perspect., <b>110<\/b>, 363-375.","DOI":"10.1289\/ehp.02110363"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Elcombe, C.R., Peffer, R.C., Wolf, D.C., Bailey, J., Bars, R., Bell, D., Cattley, R.C., Ferguson, S.S., Geter, D., Goetz, A., Goodman, J.I., Hester, S., Jacobs, A., Omiecinski, C.J., Schoeny, R., Xie, W. and Lake, B.G. (2014): Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator. Crit. Rev. Toxicol., <b>44<\/b>, 64-82.","DOI":"10.3109\/10408444.2013.835786"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Groll, N., Kollotzek, F., Goepfert, J., Joos, T.O., Schwarz, M. and Braeuning, A. (2016): Phenobarbital inhibits calpain activity and expression in mouse hepatoma cells. Biol. Chem., <b>397<\/b>, 91-96.","DOI":"10.1515\/hsz-2015-0223"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Hirose, Y., Nagahori, H., Yamada, T., Deguchi, Y., Tomigahara, Y., Nishioka, K., Uwagawa, S., Kawamura, S., Isobe, N., Lake, B.G. and Okuno, Y. (2009): Comparison of the effects of the synthetic pyrethroid Metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes. Toxicology, <b>258<\/b>, 64-69.","DOI":"10.1016\/j.tox.2009.01.007"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Huang, W., Zhang, J., Washington, M., Liu, J., Parant, J.M., Lozano, G. and Moore, D.D. (2005): Xenobiotic Stress Induces Hepatomegaly and Liver Tumors via the Nuclear Receptor Constitutive Androstane Receptor. Mol. Endocrinol., <b>19<\/b>, 1646-1653.","DOI":"10.1210\/me.2004-0520"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Kushida, M., Yamada, T. and Okuno, Y. (2016): Mode of action and assessment of human relevance for chemical-induced animal tumors. In Thresholds of Genotoxic Carcinogens (Nomi, T. and Fukushima, S., eds.), pp. 193-203, Academic Press, London.","DOI":"10.1016\/B978-0-12-801663-3.00012-1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"La Vecchia, C. and Negri, E. (2014): A review of epidemiological data on epilepsy, phenobarbital, and risk of liver cancer. Eur. J. Cancer Prev., <b>23<\/b>, 1-7.","DOI":"10.1097\/CEJ.0b013e32836014c8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Lake, B.G., Price, R.J. and Osimitz, T.G. (2015): Mode of action analysis for pesticide-induced rodent liver tumours involving activation of the constitutive androstane receptor: relevance to human cancer risk. Pest Manag. Sci., <b>71<\/b>, 829-834.","DOI":"10.1002\/ps.3854"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Luisier, R., Lempi\u00e4inen, H., Schlerbichler, N., Braeuning, A., Geissler, M., Dubost, V., M\u00fcller, A., Scheer, N., Chibout, S.D., Hara, H., Picard, F., Theil, D., Couttet, P., Vitobello, A., Grenet, O., Grasl-Kraupp, B., Ellinger-Ziegelbauer, H., Thomson, J.P., Meehan, R.R., Elcombe, C.R., Henderson, C.J., Wolf, C.R., Schwarz, M., Moulin, P., Terranova, R. and Moggs, J.G. (2014): Phenobarbital induces cell cycle transcriptional responses in humanized CAR\/PXR mouse liver. Toxicol. Sci., <b>139<\/b>, 501-511.","DOI":"10.1093\/toxsci\/kfu038"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Marx-Stoelting, P., Ganzenberg, K., Knebel, C., Schmidt, F., Rieke, S., Hammer, H., Schmidt, F., P\u00f6tz, O., Schwarz, M. and Braeuning, A. (2017): Hepatotoxic effects of cyproconazole and prochloraz in wild-type and hCAR\/hPXR mice. Arch. Toxicol., <b>91<\/b>, 2895-2907.","DOI":"10.1007\/s00204-016-1925-2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Masumoto, N., Tateno, C., Tachibana, A., Utoh, R., Morikawa, Y., Shimada, T., Momisako, H., Itamoto, T., Asahara, T. and Yoshizato, K. (2007): GH enhances proliferation of human hepatocytes grafted into immunodeficient mice with damaged liver. J. Endocrinol., <b>194<\/b>, 529-537.","DOI":"10.1677\/JOE-07-0126"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Meek, M.E., Bucher, J.R., Cohen, S.M., Dellarco, V., Hill, R.N., Lehman-McKeeman, L.D., Longfellow, D.G., Pastoor, T., Seed, J. and Patton, D.E. (2003): A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol., <b>33<\/b>, 591-653.","DOI":"10.1080\/713608373"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Monro, A. (1993): The paradoxical lack of interspecies correlation between plasma concentrations and chemical carcinogenicity. Regul. Toxicol. Pharmacol., <b>18<\/b>, 115-135.","DOI":"10.1006\/rtph.1993.1048"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Moore, J.T., Moore, L.B., Maglich, J.M. and Kliewer, S.A. (2003): Functional and structural comparison of PXR and CAR. Biochim. Biophys. Acta, <b>1619<\/b>, 235-238.","DOI":"10.1016\/S0304-4165(02)00481-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Okuda, Y., Kushida, M., Sumida, K., Nagahori, H., Nakamura, Y., Higuchi, H., Kawamura, S., Lake, B.G., Cohen, S.M. and Yamada, T. (2017): Mode of action analysis for rat hepatocellular tumors produced by the synthetic pyrethroid momfluorothrin: evidence for activation of the constitutive androstane receptor (CAR) and mitogenicity in rat hepatocytes. Toxicol. Sci., <b>158<\/b>, 412-430.","DOI":"10.1093\/toxsci\/kfx102"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Osimitz, T.G. and Lake, B.G. (2009): Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk. Crit. Rev. Toxicol., <b>39<\/b>, 501-511.","DOI":"10.1080\/10408440902914014"},{"key":"28","unstructured":"Parzefall, W., Erber, E., Sedivy, R. and Schulte-Hermann, R. (1991): Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters. Cancer Res., <b>51<\/b>, 1143-1147."},{"key":"29","doi-asserted-by":"crossref","unstructured":"Pirttiaho, H.I., Sotaniemi, E.A., Ahokas, J.T. and Pitk\u00e4nen, U. (1978): Liver size and indices of drug metabolism in epileptics. Br. J. Clin. Pharmacol., <b>6<\/b>, 273-278.","DOI":"10.1111\/j.1365-2125.1978.tb04597.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Runge, D.M., Runge, D., Dorko, K., Pisarov, L.A., Leckel, K., Kostrubsky, V.E., Thomas, D., Strom, S.C. and Michalopoulos, G.K. (1999): Epidermal growth factor- and hepatocyte growth factor-receptor activity in serum-free cultures of human hepatocytes. J. Hepatol., <b>30<\/b>, 265-274.","DOI":"10.1016\/S0168-8278(99)80073-7"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Seed, J., Carney, E.W., Corley, R.A., Crofton, K.M., DeSesso, J.M., Foster, P.M., Kavlock, R., Kimmel, G., Klaunig, J., Meek, M.E., Preston, R.J., Slikker, W., Jr., Tabacova, S., Williams, G.M., Wiltse, J., Zoeller, R.T., Fenner-Crisp, P. and Patton, D.E. (2005): Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data. Crit. Rev. Toxicol., <b>35<\/b>, 664-672.","DOI":"10.1080\/10408440591007133"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Sonich-Mullin, C., Fielder, R., Wiltse, J., Baetcke, K., Dempsey, J., Fenner-Crisp, P., Grant, D., Hartley, M., Knaap, A., Kroese, D., Mangelsdorf, I., Meek, E., Rice, J.M. and Younes, M. (2001): IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul. Toxicol. Pharmacol., <b>34<\/b>, 146-152.","DOI":"10.1006\/rtph.2001.1493"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Souza, S.C., Frick, G.P., Wang, X., Kopchick, J.J., Lobo, R.B. and Goodman, H.M. (1995): A single arginine residue determines species specificity of the human growth hormone receptor. Proc. Natl. Acad. Sci. USA, <b>92<\/b>, 959-963.","DOI":"10.1073\/pnas.92.4.959"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Tateno, C., Kataoka, M., Utoh, R., Tachibana, A., Itamoto, T., Asahara, T., Miya, F., Tsunoda, T. and Yoshizato, K. (2011): Growth hormone-dependent pathogenesis of human hepatic steatosis in a novel mouse model bearing a human hepatocyte-repopulated liver. Endocrinology, <b>152<\/b>, 1479-1491.","DOI":"10.1210\/en.2010-0953"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Tateno, C., Kawase, Y., Tobita, Y., Hamamura, S., Ohshita, H., Yokomichi, H., Sanada, H., Kakuni, M., Shiota, A., Kojima, Y., Ishida, Y., Shitara, H., Wada, N.A., Tateishi, H., Sudoh, M., Nagatsuka, S., Jishage, K. and Kohara, M. (2015a): Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA\/SCID Mice. PLoS One, <b>10<\/b>, e0142145.","DOI":"10.1371\/journal.pone.0142145"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Tateno, C., Miya, F., Wake, K., Kataoka, M., Ishida, Y., Yamasaki, C., Yanagi, A., Kakuni, M., Wisse, E., Verheyen, F., Inoue, K., Sato, K., Kudo, A., Arii, S., Itamoto, T., Asahara, T., Tsunoda, T. and Yoshizato, K. (2013): Morphological and microarray analyses of human hepatocytes from xenogeneic host livers. Lab. Invest., <b>93<\/b>, 54-71.","DOI":"10.1038\/labinvest.2012.158"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Tateno, C., Yamamoto, T., Utoh, R., Yamasaki, C., Ishida, Y., Myoken, Y., Oofusa, K., Okada, M., Tsutsui, N. and Yoshizato, K. (2015b): Chimeric Mice with Hepatocyte-humanized Liver as an Appropriate Model to Study Human Peroxisome Proliferator-activated Receptor-\u03b1. Toxicol. Pathol., <b>43<\/b>, 233-248.","DOI":"10.1177\/0192623314544378"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Tateno, C., Yoshizane, Y., Saito, N., Kataoka, M., Utoh, R., Yamasaki, C., Tachibana, A., Soeno, Y., Asahina, K., Hino, H., Asahara, T., Yokoi, T., Furukawa, T. and Yoshizato, K. (2004): Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am. J. Pathol., <b>165<\/b>, 901-912.","DOI":"10.1016\/S0002-9440(10)63352-4"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Tsuji, R., Yamada, T. and Kawamura, S. (2012): Mammal Toxicology of Synthetic Pyrethroids. In Pyrethroids: From Chrysanthemum to Modern Industrial Insecticide. Topics in Current Chemistry Vol. 314 (Matsuo, N. and Mori, T., eds.), pp. 83-111, Springer Berlin \/ Heidelberg.","DOI":"10.1007\/128_2011_269"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Wood, C.E., Hukkanen, R.R., Sura, R., Jacobson-Kram, D., Nolte, T., Odin, M. and Cohen, S.M. (2015): Scientific and regulatory policy committee (SRPC) review: Interpretation and use of cell proliferation data in cancer risk assessment. Toxicol. Pathol., <b>43<\/b>, 760-775.","DOI":"10.1177\/0192623315576005"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Yamada, T., Kikumoto, H., Lake, B.G. and Kawamura, S. (2015): Lack of effect of metofluthrin and sodium phenobarbital on replicative DNA synthesis and Ki-67 mRNA expression in cultured human hepatocytes. Toxicol. Res., <b>4<\/b>, 901-913.","DOI":"10.1039\/C4TX00217B"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Yamada, T., Okuda, Y., Kushida, M., Sumida, K., Takeuchi, H., Nagahori, H., Fukuda, T., Lake, B.G., Cohen, S.M. and Kawamura, S. (2014): Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an <i>in vivo<\/i> study using a chimeric mouse with humanized liver. Toxicol. Sci., <b>142<\/b>, 137-157.","DOI":"10.1093\/toxsci\/kfu173"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Yamada, T., Uwagawa, S., Okuno, Y., Cohen, S.M. and Kaneko, H. (2009): Case study: an evaluation of the human relevance of the synthetic pyrethroid metofluthrin-induced liver tumors in rats based on mode of action. Toxicol. Sci., <b>108<\/b>, 59-68.","DOI":"10.1093\/toxsci\/kfp007"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/42\/6\/42_773\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T05:56:24Z","timestamp":1570341384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/42\/6\/42_773\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.42.773","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}